Metabolic associated fatty liver disease and COVID-19: a double whammy?
作者信息
Xian Lin Jaime Hui, Aravamudan Veeraraghavan Meyyur
机构信息
Department of Medicine, Woodlands Health Campus, Singapore.
出版信息
Singapore Med J. 2022 Sep;63(9):542-544. doi: 10.11622/smedj.2020141. Epub 2020 Sep 21.
Abstract
摘要
相似文献
1
Metabolic associated fatty liver disease and COVID-19: a double whammy?代谢相关脂肪性肝病与2019冠状病毒病：双重打击？
Singapore Med J. 2022 Sep;63(9):542-544. doi: 10.11622/smedj.2020141. Epub 2020 Sep 21.
2
COVID-19 and diabetes-double whammy.新冠病毒病与糖尿病——双重打击。
QJM. 2023 Feb 24;116(2):143. doi: 10.1093/qjmed/hcac047.
3
Response to: COVID-19 and diabetes-double whammy.回应：2019冠状病毒病与糖尿病——双重打击
QJM. 2023 Feb 24;116(2):144-145. doi: 10.1093/qjmed/hcac048.
4
COVID-19 double whammy - Vaccine and variants.新冠疫情的双重打击——疫苗与变种毒株。
Int J Clin Pharmacol Ther. 2021 Apr;59(4):267-268. doi: 10.5414/CP203994.
5
COVID 19 pandemic and lockdown: A double whammy for patients with thalassemia.新冠疫情与封锁：给地中海贫血患者带来双重打击。
Acta Biomed. 2021 Jul 1;92(3):e2021212. doi: 10.23750/abm.v92i3.10880.
6
Multisystem Inflammatory Syndrome in Children Related to COVID-19 With Urticarial Vasculitis - A Double Whammy!与新冠病毒相关的儿童多系统炎症综合征合并荨麻疹性血管炎——双重打击！
Indian Pediatr. 2021 Sep 15;58(9):894-895. doi: 10.1007/s13312-021-2317-0.
7
Reply to: 'No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease'.回复：“无证据表明代谢相关脂肪性肝病中严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的肝脏摄取增加” 。
J Hepatol. 2020 Sep;73(3):718-719. doi: 10.1016/j.jhep.2020.04.039. Epub 2020 May 6.
8
COVID-19, adaptative immune response and metabolic-associated liver disease.COVID-19、适应性免疫反应与代谢相关肝疾病。
Liver Int. 2021 Nov;41(11):2560-2577. doi: 10.1111/liv.15061. Epub 2021 Sep 28.
9
COVID-19 and tuberculosis: the double whammy of respiratory pathogens.新型冠状病毒肺炎与结核病：呼吸道病原体的双重打击。
Eur Respir Rev. 2022 Apr 13;31(164). doi: 10.1183/16000617.0264-2021. Print 2022 Jun 30.
10
COVID-19 and heatwaves: a double whammy for Indian cities.新冠疫情与热浪：给印度城市带来双重打击。
Lancet Planet Health. 2020 Aug;4(8):e315-e316. doi: 10.1016/S2542-5196(20)30170-4. Epub 2020 Jul 27.
本文引用的文献
1
Metabolic associated fatty liver disease increases coronavirus disease 2019 disease severity in nondiabetic patients.代谢相关脂肪性肝病增加非糖尿病患者 2019 冠状病毒病严重程度。
J Gastroenterol Hepatol. 2021 Jan;36(1):204-207. doi: 10.1111/jgh.15112. Epub 2020 Jun 5.
2
Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores.代谢功能障碍相关脂肪性肝病且纤维化评分升高的患者感染新型冠状病毒肺炎后出现重症的风险。
Gut. 2020 Aug;69(8):1545-1547. doi: 10.1136/gutjnl-2020-321611. Epub 2020 May 15.
3
Obesity Is a Risk Factor for Greater COVID-19 Severity.肥胖是新冠病毒疾病（COVID-19）病情加重的一个风险因素。
Diabetes Care. 2020 Jul;43(7):e72-e74. doi: 10.2337/dc20-0682. Epub 2020 May 14.
4
No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease.在代谢相关脂肪性肝病中，没有证据表明严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的肝脏摄取增加。
J Hepatol. 2020 Sep;73(3):717-718. doi: 10.1016/j.jhep.2020.04.035. Epub 2020 Apr 30.
5
Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis.患有MAFLD的年轻患者患重症COVID-19疾病的风险增加：一项多中心初步分析。
J Hepatol. 2020 Sep;73(3):719-721. doi: 10.1016/j.jhep.2020.04.027. Epub 2020 Apr 26.
6
Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease.致编辑的信：肥胖作为代谢相关脂肪性肝病患者感染 COVID-19 时病情更严重的风险因素。
Metabolism. 2020 Jul;108:154244. doi: 10.1016/j.metabol.2020.154244. Epub 2020 Apr 19.
7
Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study.新型冠状病毒肺炎患者的非酒精性脂肪性肝病：一项回顾性研究。
J Hepatol. 2020 Aug;73(2):451-453. doi: 10.1016/j.jhep.2020.03.044. Epub 2020 Apr 8.
8
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.代谢相关脂肪性肝病新定义：国际专家共识声明。
J Hepatol. 2020 Jul;73(1):202-209. doi: 10.1016/j.jhep.2020.03.039. Epub 2020 Apr 8.
9
Liver injury during highly pathogenic human coronavirus infections.高致病性人冠状病毒感染期间的肝损伤。
Liver Int. 2020 May;40(5):998-1004. doi: 10.1111/liv.14435. Epub 2020 Mar 30.
10
Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection.单细胞 RNA 测序数据分析受体 ACE2 的表达揭示了不同人体器官易感染 2019-nCoV 的潜在风险。
Front Med. 2020 Apr;14(2):185-192. doi: 10.1007/s11684-020-0754-0. Epub 2020 Mar 12.
Zotero 插件